✦ LIBER ✦

Blink reflex excitability is abnormal in patients with periodic leg movements in sleep

✍ Scribed by Dr. Regula S. Briellmann; Kai M. Rösler; Christian W. Hess

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 489 KB
Volume: 11
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.870110617

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The excitability of the late component of the blink reflex was measured in 19 patients with periodic leg movements in sleep (PLMS) and in 18 control patients with other sleep complaints. PLMS patients were not different from controls regarding age, body mass index, and apneas and hypopneas per hour of sleep. The latencies of the R1 and R2 components of the blink reflex were not different between the groups. However, in PLMS, the excitability of the R2 response was markedly enhanced: The second R2 response to a pair of stimuli given at an interval of 500 ms was in PLMS 59.5% (range 21–87%) of the first R2 response and in controls 18.8% (range 2–79%) (p < 0.0001, Mann‐Whitney U test). These results provide further evidence of an altered motor control in PLMS, which is likely to be located subcortically and possibly related to the dopaminergic striaitopallidal system.

📜 SIMILAR VOLUMES

Periodic leg movements and REM sleep wit

Periodic leg movements and REM sleep without atonia in Parkinson's disease with camptocormia

✍ Sophie Lavault; Frederic Bloch; Jean-Luc Houeto; Eric Konofal; Marie-Laure Welte 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 1 views

## Abstract Camptocormia (a flexion of the trunk that only appears when standing or walking) affects a minority of patients with Parkinson's disease (PD). As it responds poorly to levodopa and is associated with reduced midbrain and pons volume, it may result from non‐dopaminergic, brainstem lesion

Cortical excitability is abnormal in pat

Cortical excitability is abnormal in patients with the “fixed dystonia” syndrome

✍ Laura Avanzino; Davide Martino; Bart P. C. van de Warrenburg; Susanne A. Schneid 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

## Abstract A form of fixed dystonia (FD) without evidence of basal ganglia lesions or neurodegeneration has been recently characterized (Schrag et al., Brain 2004;127:2360‐2372), which may overlap the clinical spectrum of either complex regional pain syndrome or psychogenic dystonia. Transcranial

The movement-related cortical potential

✍ W. Van Der Kamp; Dr. J. C. Rothwell; P. D. Thompson; B. L. Day; C. D. Marsden 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 1 views

## Abstract Voluntary movements, such as the self‐paced finger extension task used in the present experiments, are preceded by a slowly rising negative electroencephalographic potential [the movement‐related cortical potential (MRCP)]. The early NS1 component of the potential was no different in pa

Restless legs syndrome, rapid eye moveme

Restless legs syndrome, rapid eye movement sleep behavior disorder, and hypersomnia in patients with two parkin mutations

✍ Nadège Limousin; Eric Konofal; Elias Karroum; Ebba Lohmann; Ioannis Theodorou; A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract __Parkin__ gene mutations cause a juvenile parkinsonism. Patients with these mutations may commonly exhibit REM sleep behaviour disorders, but other sleep problems (insomnia, sleepiness, restless legs syndrome) have not been studied. The aim of this study was to evaluate the sleep‐wake

Sleep laboratory studies in periodic lim

Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole

✍ M. Saletu; P. Anderer; B. Saletu; C. Hauer; M. Mandl; B. Semler; G. Saletu-Zyhla 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

Periodic limb movement disorder (PLMD) occurs in a variety of sleep disorders and can cause insomnia as well as hypersomnia with daytime somnolence. The aim of this study was to investigate 12 untreated PLMD patients as compared with 12 normal controls and to measure the acute effects of 0.5 mg ropi